Mounjaro and Co-Codamol: Is It Safe to Take Them Together?

Does Mounjaro interact directly with co-codamol?

There is no named drug-drug interaction flagged between tirzepatide and co-codamol in the way that, say, a blood-thinning medicine has a documented interaction with a specific antibiotic. What exists instead is a functional concern rooted in how Mounjaro works. Tirzepatide reduces how fast the stomach empties its contents into the small intestine. That process is central to why people feel fuller for longer, and it is also why the timing and speed of oral medicine absorption can shift.

For most short-course painkillers this is unlikely to cause a clinically significant problem, but it is worth knowing. The NHS notes that medicines taken by mouth could be absorbed more slowly during tirzepatide treatment, and the Mounjaro Summary of Product Characteristics on the eMC addresses this directly under drug interactions. If you are relying on co-codamol to hit quickly (for a migraine, for example) slower absorption is relevant. You can read more about how tirzepatide works as a medicine if the mechanism is useful context.

The interaction question is genuinely a clinical one rather than a blanket yes-or-no, which is why disclosing all regular and occasional medicines at consultation matters.

What does the codeine component add to the concern?

Paracetamol and codeine behave quite differently in the body. Codeine is an opioid. One of opioids' well-known effects is slowing gut motility, they reduce the rhythmic contractions that move food and waste through the digestive tract. Tirzepatide already reduces gastric emptying. Stack an opioid on top and you are adding two gut-slowing influences at once.

In practice this means a higher likelihood of constipation, and potentially more pronounced nausea, particularly in the early weeks of Mounjaro when gastrointestinal side effects are most common anyway. For a one-off dose of co-codamol this is unlikely to be dangerous, but it is uncomfortable and it is the kind of thing worth knowing before you take it. Our detailed page on codeine and Mounjaro goes further into the opioid-specific considerations if that is what you are primarily concerned about.

The NHS tirzepatide medicines page lists constipation and nausea among the most common side effects of Mounjaro, context that matters when layering in a medicine that can compound both.

Is paracetamol alone a safer choice while on Mounjaro?

Paracetamol on its own does not carry the gut-motility concern that codeine does. For many people on tirzepatide who need mild-to-moderate pain relief, plain paracetamol at standard doses is a more straightforward option, though absorption timing may still be slightly altered by slowed gastric emptying, the clinical significance of that for paracetamol is generally low. Our page on taking paracetamol on Mounjaro covers the specifics in full.

If you are unsure whether plain paracetamol is appropriate for your particular pain, or if you have been relying on co-codamol regularly, that frequency matters. Regular codeine use alongside Mounjaro is a more substantive conversation than an occasional tablet, and it is exactly the kind of thing a prescriber needs to know about. The full guidance on co-codamol with Mounjaro addresses the question from a prescribing perspective. Worth bookmarking if this is a frequent decision for you.

A note on timing that comes up more than you might expect: people starting Mounjaro around a bank holiday, or planning to order their next pen before heading away, sometimes stockpile OTC painkillers at the same time, and wonder mid-holiday whether co-codamol is fine. If you are also navigating Mounjaro codes to access your treatment, the honest answer to the co-codamol question is the same as it would be at home: occasional use is unlikely to be catastrophic, but your prescriber's view on your specific situation is always preferable to a best guess.

What should you tell your prescriber or pharmacist?

The practical action is straightforward. At any consultation (including a repeat review) list every medicine you take, including things bought over the counter. Co-codamol is available without a prescription at low strengths from a pharmacy, but that does not make it irrelevant to a prescribing decision. A prescriber or pharmacist can weigh up your full picture: how long you have been on Mounjaro, which dose, whether you have had GI side effects, and what the co-codamol is for.

For ongoing pain management needs rather than occasional use, there may be better-suited alternatives. That conversation belongs with a clinician who knows your history. You can explore Mounjaro treatment information or read frequently asked clinical questions if you want broader context before your next review. If you have not yet started treatment and are wondering how your current medicines would be assessed, starting a free consultation is the right first step, every application is read by a GPhC-registered prescriber, not a decision tree, so nuanced medication histories are handled properly.